Food and Drug Administration: These are not drugs, can not cure!

Medical Network January 29 hearing On the afternoon of January 23, the State Food and Drug Administration held a press conference. At the meeting, Zhang Jinjing, the inspector of the State Food and Drug Administration's specialties registration department, said: 'Consumers should pay attention to that health food is not a medicine and can not be used as a substitute for medicines. Treatment of disease, so as not to delay the disease '.

According to Zhang Jinjing introduction, in July 2017, the State Council department of food safety and other 9 departments have deployed a year-long food, health food fraud and false propaganda and remediation work across the country, the object covers food, health food production, management, import units, Tripartite platform operators and stakeholders, as well as advertising units, covering all aspects of food, health food production and marketing.

By the end of 2017, a total of 870,000 production and operation units of food and health food products had been inspected, over 12,000 cases of illegal activities were investigated and dealt with, involving an amount of 360 million yuan and a total fine of 180 million yuan.

As early as January 2017, the State Food and Drug Administration issued the "2017 Food drug Supervision of the State Food and Drug Administration focused on sampling the list of notices, "involves Healthy food , Special dietary foods, etc., a total of 774 companies in 28 categories, of which Health products produce enterprise Thirty, Tomson times Kin, Beijing Tong Ren Tang, Hangzhou Neptune, Shippudeno and other big companies are also among them.

According to the documents, health care (functional) foods are a type of food that has the commonality of common foods and can regulate the function of the human body and is suitable for consumption by a specific group of people. However, Not to treat the disease for the purpose.

Therefore, health care products are not drugs, can not be directly used to treat diseases, it is a human mechanism regulator, nutritional supplements, but to sell high-priced health care products to cheat the elderly money, for now, really nothing new.

This is as prompted by the General Administration, the Spring Festival approaching, when consumers buy health food to be fully licensed, reputable regular sales sites to buy, do not blindly participate in any product sales for the purpose of knowledge lectures, expert reports, etc .; to recognize Clear health food approval number, check the official website to confirm the relevant product information; the same time should be carefully read the health food label instructions.

▍ 400 billion market, pharmaceutical companies must contend for

In recent years, with the improvement of people's living standards, health awareness has also been increasing, health food products have been included in our 12th Five-Year Plan, a national pursuit health The rigid demand.

Relevant research data show that from 2016 to 2021, China's health care products sales will grow from 260 billion yuan to 400 billion yuan.

In 2016, the State Food and Drug Administration formally released the Measures for the Administration and Registration of Health Foods, which was officially implemented on July 1, and the health food commonly known as 'blue hat' will usher in a drastic change.

Well-known health products manufacturer Tomson times Health had previously said that in accordance with the Food Safety Law and the implementation rules clearly stipulated that health products need to register, at least three years or more, if the implementation of the filing system, will make time shortened, only three month.

Some analysts believe that with the filing system landing, health food registration tends to be simple, due to the monopoly of the document control will also be broken, the cost of pharmaceutical companies will be reduced, which makes many pharmaceutical companies to see the health care products market Expansion capacity.

At present, many domestic and foreign pharmaceutical companies have laid out health products markets in succession, for example, Jiangzhong Pharmaceutical, which started business in health products earlier, accounted for more than 14.9% of the total revenue of healthcare products in the first half of 2017. Foreign pharmaceutical companies Pfizer, GSK and other health products are also made force, very optimistic about China's health products market.

There is no doubt that China's health care products market usher in a broad space for development, a new round of wars has come. Under such circumstances, the inspection companies will also face more stringent.